Consensus recommendations for the use of automated insulin delivery technologies in clinical practice

M Phillip, R Nimri, RM Bergenstal… - Endocrine …, 2023 - academic.oup.com
The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

2022 National standards for diabetes self-management education and support

J Davis, AH Fischl, J Beck, L Browning… - The science of …, 2022 - journals.sagepub.com
Purpose: The National Standards for Diabetes Self-Management Education and Support
(DSMES) provide guidance and evidence-based, quality practice for all DSMES services …

Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative

S Majidi, O Ebekozien, N Noor, SK Lyons… - Clinical …, 2021 - Am Diabetes Assoc
Health care inequities among racial and ethnic groups remain prevalent. For people with
type 1 diabetes who require increased medical access and care, disparities are seen in …

Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes

AF Walker, KK Hood, MJ Gurka, SL Filipp… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE Disparities in type 1 diabetes related to use of technologies like continuous
glucose monitors (CGMs) and utilization of diabetes care are pronounced based on …

Interventions to address global inequity in diabetes: international progress

AF Walker, S Graham, L Maple-Brown, LE Egede… - The Lancet, 2023 - thelancet.com
Diabetes is a serious chronic disease with high associated burden and disproportionate
costs to communities based on socioeconomic, gender, racial, and ethnic status. Addressing …

The role of structural racism and geographical inequity in diabetes outcomes

S Agarwal, AN Wade, JC Mbanya, C Yajnik, N Thomas… - The Lancet, 2023 - thelancet.com
Diabetes is pervasive, exponentially growing in prevalence, and outpacing most diseases
globally. In this Series paper, we use new theoretical frameworks and a narrative review of …

Disparities in hemoglobin A1c levels in the first year after diagnosis among youths with type 1 diabetes offered continuous glucose monitoring

A Addala, V Ding, DP Zaharieva, FK Bishop… - JAMA Network …, 2023 - jamanetwork.com
Importance Continuous glucose monitoring (CGM) is associated with improvements in
hemoglobin A 1c (HbA 1c) in youths with type 1 diabetes (T1D); however, youths from …

The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence

MJ Redondo, I Libman, DM Maahs, SK Lyons… - Diabetes …, 2021 - Am Diabetes Assoc
The American Diabetes Association 2020 Standards of Medical Care in Diabetes
(Standards of Care) recommends a hemoglobin A1c (A1C) of< 7%(53 mmol/mol) for many …

Eradicating racism: an endocrine society policy perspective

R Dhaliwal, RI Pereira, AM Diaz-Thomas… - The Journal of …, 2022 - academic.oup.com
Abstract The Endocrine Society recognizes racism as a root cause of the health disparities
that affect racial/ethnic minority communities in the United States and throughout the world …

Racial disparities in access and use of diabetes technology among adult patients with type 1 diabetes in a US academic medical center

S Kanbour, M Jones, MS Abusamaan, C Nass… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE Recent studies highlight racial disparities in insulin pump (PUMP) and
continuous glucose monitor (CGM) use in children and adolescents with type 1 diabetes …